DM
Deerfield Management Portfolio holdings
AUM
$5.51B
1-Year Return
12.76%
This Quarter Return
+18.6%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$6.69B
AUM Growth
+$682M
(+11%)
Cap. Flow
-$874M
Cap. Flow
% of AUM
-13.05%
Top 10 Holdings %
Top 10 Hldgs %
54.02%
Holding
681
New
246
Increased
85
Reduced
72
Closed
235
Top Buys
| 1 |
Neurocrine Biosciences
NBIX
|
$72.1M |
| 2 |
Indivior
INDV
|
$49.7M |
| 3 |
BCAX
Bicara Therapeutics Inc. Common Stock
BCAX
|
$45.7M |
| 4 |
Merus
MRUS
|
$32.9M |
| 5 |
Viatris
VTRS
|
$30.2M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$102M |
| 2 |
Surgery Partners
SGRY
|
$94.4M |
| 3 |
Catalyst Pharmaceutical
CPRX
|
$57.6M |
| 4 |
BioNTech
BNTX
|
$49.8M |
| 5 |
Integra LifeSciences
IART
|
$42.8M |
Sector Composition
| 1 | Healthcare | 87.45% |
| 2 | Industrials | 0.72% |
| 3 | Technology | 0.55% |
| 4 | Financials | 0.42% |
| 5 | Consumer Discretionary | 0.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Sabra Healthcare REIT
SBRA
$4.56B
| $444K | 0.01% |
23,848
-2,812
| -11% | -$52.3K |
|
302
Inovio Pharmaceuticals
INO
$148M
| $442K | 0.01% |
+76,523
| New | +$442K |
|
303
Kinsale Capital Group
KNSL
$10.6B
| $440K | 0.01% |
+945
| New | +$440K |
|
304
Cigna
CI
$81.5B
| $437K | 0.01% |
1,260
+523
| +71% | +$181K |
|
305
Charles River Laboratories
CRL
$8.07B
| $434K | 0.01% |
+2,204
| New | +$434K |
|
306
Sprinklr
CXM
$1.91B
| $431K | 0.01% |
+55,785
| New | +$431K |
|
307
NNN REIT
NNN
$8.18B
| $431K | 0.01% |
+8,891
| New | +$431K |
|
308
TKO Group
TKO
$15.9B
| $430K | 0.01% |
+3,472
| New | +$430K |
|
309
Lincoln National
LNC
$7.98B
| $428K | 0.01% |
+13,586
| New | +$428K |
|
310
American Coastal Insurance
ACIC
$554M
| $426K | 0.01% |
+37,834
| New | +$426K |
|
|
CRGX
311
DELISTED
CARGO Therapeutics
CRGX
| $426K | 0.01% |
+23,078
| New | +$426K |
|
312
CVB Financial
CVBF
$2.8B
| $424K | 0.01% |
+23,802
| New | +$424K |
|
313
US Foods
USFD
$17.5B
| $421K | 0.01% |
+6,845
| New | +$421K |
|
314
Sunrun
RUN
$4.19B
| $421K | 0.01% |
+23,300
| New | +$421K |
|
315
Cooper Companies
COO
$13.5B
| $410K | 0.01% |
3,716
-12,893
| -78% | -$1.42M |
|
316
Veracyte
VCYT
$2.55B
| $410K | 0.01% |
+12,032
| New | +$410K |
|
317
Waste Management
WM
$88.6B
| $406K | 0.01% |
+1,958
| New | +$406K |
|
318
Northwest Natural Holdings
NWN
$1.71B
| $406K | 0.01% |
+9,940
| New | +$406K |
|
319
DaVita
DVA
$9.86B
| $405K | 0.01% |
+2,472
| New | +$405K |
|
320
AMERISAFE
AMSF
$871M
| $400K | 0.01% |
+8,283
| New | +$400K |
|
321
Goldman Sachs
GS
$223B
| $400K | 0.01% |
+808
| New | +$400K |
|
322
Envista
NVST
$3.54B
| $399K | 0.01% |
+20,167
| New | +$399K |
|
323
Olema Pharmaceuticals
OLMA
$570M
| $398K | 0.01% |
33,296
+1,891
| +6% | +$22.6K |
|
|
SVC
324
Service Properties Trust
SVC
$481M
| $397K | 0.01% |
87,133
+58,888
| +208% | +$269K |
|
325
Future Fuel
FF
$173M
| $396K | 0.01% |
+68,916
| New | +$396K |
|